JP5561850B2 - Method for producing protein degradation product - Google Patents
Method for producing protein degradation product Download PDFInfo
- Publication number
- JP5561850B2 JP5561850B2 JP2009240208A JP2009240208A JP5561850B2 JP 5561850 B2 JP5561850 B2 JP 5561850B2 JP 2009240208 A JP2009240208 A JP 2009240208A JP 2009240208 A JP2009240208 A JP 2009240208A JP 5561850 B2 JP5561850 B2 JP 5561850B2
- Authority
- JP
- Japan
- Prior art keywords
- pressure vessel
- degradation product
- protein
- mixture
- temperature
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000007857 degradation product Substances 0.000 title claims description 27
- 230000017854 proteolysis Effects 0.000 title claims description 27
- 238000004519 manufacturing process Methods 0.000 title claims description 21
- 239000000203 mixture Substances 0.000 claims description 27
- 102000004169 proteins and genes Human genes 0.000 claims description 27
- 108090000623 proteins and genes Proteins 0.000 claims description 27
- 241000207961 Sesamum Species 0.000 claims description 26
- 235000003434 Sesamum indicum Nutrition 0.000 claims description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 25
- 238000000034 method Methods 0.000 claims description 19
- 230000002401 inhibitory effect Effects 0.000 claims description 16
- 239000007788 liquid Substances 0.000 claims description 12
- 238000010438 heat treatment Methods 0.000 claims description 7
- 210000004885 white matter Anatomy 0.000 claims 1
- 235000018102 proteins Nutrition 0.000 description 26
- 102100030988 Angiotensin-converting enzyme Human genes 0.000 description 17
- 238000012360 testing method Methods 0.000 description 11
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 239000008346 aqueous phase Substances 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 238000005119 centrifugation Methods 0.000 description 5
- 239000012153 distilled water Substances 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 230000036772 blood pressure Effects 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000003531 protein hydrolysate Substances 0.000 description 4
- UUUHXMGGBIUAPW-UHFFFAOYSA-N 1-[1-[2-[[5-amino-2-[[1-[5-(diaminomethylideneamino)-2-[[1-[3-(1h-indol-3-yl)-2-[(5-oxopyrrolidine-2-carbonyl)amino]propanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbon Chemical compound C1CCC(C(=O)N2C(CCC2)C(O)=O)N1C(=O)C(C(C)CC)NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C1CCCN1C(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C1CCC(=O)N1 UUUHXMGGBIUAPW-UHFFFAOYSA-N 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 108090000882 Peptidyl-Dipeptidase A Proteins 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 229910001220 stainless steel Inorganic materials 0.000 description 3
- 239000010935 stainless steel Substances 0.000 description 3
- 230000035488 systolic blood pressure Effects 0.000 description 3
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000035487 diastolic blood pressure Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 230000003301 hydrolyzing effect Effects 0.000 description 2
- 108010028463 kappa-casein glycomacropeptide Proteins 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 235000019454 L-leucine Nutrition 0.000 description 1
- 239000004395 L-leucine Substances 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 208000032851 Subarachnoid Hemorrhage Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 229940030600 antihypertensive agent Drugs 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 230000004531 blood pressure lowering effect Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000010908 decantation Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000002036 drum drying Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 229960003136 leucine Drugs 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 201000009925 nephrosclerosis Diseases 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000011699 spontaneously hypertensive rat Methods 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
Images
Landscapes
- Medicines Containing Plant Substances (AREA)
Description
本発明は、ゴマ種子由来の蛋白質から得られる蛋白質分解物の製造方法に関し、更に詳しくはゴマ種子由来の蛋白質を亜臨界状態の水により加水分解することによって得られるアンジオテンシン変換酵素阻害活性を有する蛋白質分解物の製造方法に関する。 The present invention relates to a method for producing a protein degradation product obtained from a protein derived from sesame seeds, and more specifically, a protein having an angiotensin converting enzyme inhibitory activity obtained by hydrolyzing a protein derived from sesame seeds with subcritical water. The present invention relates to a method for producing a decomposition product.
従来、高血圧症は代表的な生活習慣病であり、脳出血、クモ膜下出血、脳梗塞、心筋梗塞、狭心症、腎硬化症等、様々な合併症を引き起こすことが知られている。高血圧症の原因にはアンジオテンシン変換酵素(以下、ACEという)が関与することが知られており、ACEの阻害活性を有するものが高血圧症を防止するものとして注目されている。かかるACEの阻害活性を有するものの一つとして食品素材タンパク質の酵素分解物であるペプチドが提案されており、かかるペプチドの製造方法として、ゼラチンに酵素コラゲナーゼを作用させてACEの阻害活性を有するペプチドを得る方法(例えば、特許文献1参照)、ゴマ種子由来の蛋白質を酵素分解する方法(例えば、特許文献2参照)、乳質原料物質等からκカゼイングリコマクロペプチドを製造し、このκカゼイングリコマクロペプチドを蛋白質分解酵素で加水分解する方法(例えば、特許文献3参照)、蛋白質を300〜400℃の温度で221〜1000気圧の高温・高圧下の超臨界状態又は亜臨界状態の水で加水分解する方法(例えば、特許文献4参照)等が提案されている。 Conventionally, hypertension is a typical lifestyle-related disease and is known to cause various complications such as cerebral hemorrhage, subarachnoid hemorrhage, cerebral infarction, myocardial infarction, angina pectoris, nephrosclerosis and the like. It is known that angiotensin converting enzyme (hereinafter referred to as ACE) is involved in the cause of hypertension, and those having ACE inhibitory activity are attracting attention as preventing hypertension. A peptide that is an enzyme degradation product of food material protein has been proposed as one of such ACE inhibitory activities. As a method for producing such a peptide, a peptide having an ACE inhibitory activity is prepared by allowing the enzyme collagenase to act on gelatin. A method for obtaining (for example, see Patent Document 1), a method for enzymatically degrading a protein derived from sesame seed (for example, see Patent Document 2), a κ casein glycomacropeptide from a milk raw material, etc., and this κ casein glycomacropeptide A protein is hydrolyzed with a proteolytic enzyme (see, for example, Patent Document 3), and a protein is hydrolyzed with supercritical or subcritical water under a high temperature and high pressure of 221 to 1000 atmospheres at a temperature of 300 to 400 ° C. A method (for example, refer to Patent Document 4) has been proposed.
しかし、酵素を用いた製造方法はその方法自体が複雑であって製造効率が悪く、また高温・高圧下の超臨界状態又は亜臨界状態の水で加水分解する方法は相応の設備と熟練を要し、それでもなお作業の危険性が高いという問題がある。 However, the production method using an enzyme is complicated and the production efficiency is low, and the method of hydrolysis with supercritical or subcritical water under high temperature and high pressure requires appropriate equipment and skill. However, there is still a problem that the risk of work is high.
本発明が解決しようとする課題は、ACE阻害活性を有する蛋白質分解物を安全に量産できる製造方法を提供する処にある。 The problem to be solved by the present invention is to provide a production method capable of safely mass-producing a protein degradation product having ACE inhibitory activity.
本発明者は、前記の課題を解決するべく研究した結果、ゴマ種子由来の蛋白質を特定条件下の亜臨界状態の水で加水分解する方法が正しく好適であることを見出した。 As a result of researches to solve the above-mentioned problems, the present inventor has found that a method of hydrolyzing a protein derived from sesame seeds with subcritical water under specific conditions is correctly suitable.
すなわち本発明は、蛋白質分解物の製造方法(以下、本発明の製造方法という)に係り、下記の第1工程、第2工程及び第3工程を含む工程を経ることを特徴とする。
第1工程:ゴマ種子由来の蛋白質1質量部に対して水を10〜50質量部の割合で混合し、その混合物を耐圧容器内に密閉して、耐圧容器内の雰囲気ガスをN2ガスで置換し、与圧した後、耐圧容器内の混合物を10〜90分間で160〜280℃の到達温度となるよう且つ到達温度時の耐圧容器内の圧力が4.0〜8.0MPaとなるように加熱する工程。
第2工程:160〜280℃の同温度で0〜20分間保持する工程。
第3工程:耐圧容器内の生成した加水分解物を冷却し、耐圧容器から取り出して、液体部を分離し、分離した液体部を乾燥する工程。
That is, the present invention relates to a method for producing a protein degradation product (hereinafter referred to as the production method of the present invention), and is characterized by passing through the following steps including the first step, the second step and the third step.
First step: 10 to 50 parts by mass of water is mixed with 1 part by mass of protein derived from sesame seeds, the mixture is sealed in a pressure vessel, and the atmosphere gas in the pressure vessel is N 2 gas. After the replacement and pressurization, the mixture in the pressure vessel is brought to an ultimate temperature of 160 to 280 ° C. in 10 to 90 minutes, and the pressure in the pressure vessel is 4.0 to 8.0 MPa at the ultimate temperature. The process of heating to.
2nd process: The process hold | maintained at the same temperature of 160-280 degreeC for 0-20 minutes.
3rd process: The process which cools the produced | generated hydrolyzate in a pressure vessel, takes out from a pressure vessel, isolate | separates a liquid part, and dries the isolate | separated liquid part.
本発明の製造方法では、ゴマ種子由来の蛋白質を亜臨界状態の水により特定の条件下で加水分解する。かかるゴマ種子としては、生ゴマ種子、煎りゴマ種子、練りゴマ種子、切りゴマ種子、脱脂ゴマ種子等の各種のゴマ種子が挙げられるが、なかでも生ゴマ種子、煎りゴマ種子及び脱脂ゴマ種子が好ましい。本発明の製造方法では、蛋白質分解物を効率的に得るために、かかるゴマ種子から抽出したゴマ種子由来の蛋白質を使用する。 In the production method of the present invention, a protein derived from sesame seeds is hydrolyzed under specific conditions with subcritical water. Examples of such sesame seeds include various sesame seeds such as raw sesame seeds, roasted sesame seeds, kneaded sesame seeds, cut sesame seeds, and defatted sesame seeds. preferable. In the production method of the present invention, a protein derived from sesame seeds extracted from such sesame seeds is used in order to efficiently obtain a protein degradation product.
ゴマ種子由来の蛋白質は、それ自体は公知の方法により得ることができ、例えば、Journal of Food Science,Vol.47p.457−460(1982)に記載の方法により得ることができる。かかる方法によれば、原料のゴマ種子をヘキサンにより脱脂し、脱脂したゴマ種子処理物から蛋白質をアルカリ溶液により抽出し、更に等電点沈殿法等の処理により沈殿物として得ることができる。 A protein derived from sesame seeds can be obtained by a method known per se, for example, see Journal of Food Science, Vol. 47p. 457-460 (1982). According to this method, the raw sesame seeds are defatted with hexane, the protein is extracted from the defatted sesame seed treated product with the alkaline solution, and further obtained as a precipitate by a treatment such as an isoelectric precipitation method.
第1工程では、先ずゴマ種子由来の蛋白質(以下、蛋白質という)と水とを混合して混合物とする。水の量は蛋白質を加水分解するのに必要な科学量論的量以上であれば十分であるが、蛋白質1質量部に対し水を10〜50質量部の割合で混合する。またこの段階での混合物の温度は10〜80℃とするのが好ましい。この混合物を耐圧容器内に密閉して、耐圧容器内の混合物の到達温度が160〜280℃、好ましくは200〜240℃となるように加熱する。到達温度に達するまでの加熱時間は、10〜90分間とするが、20〜60分間とするのが好ましく、この際の昇温速度は3〜20℃/分とするのが好ましい。耐圧容器内の雰囲気ガスは、予めN2ガスで置換し、与圧しておく。 In the first step, first, a protein derived from sesame seeds (hereinafter referred to as protein) and water are mixed to obtain a mixture. The amount of water is sufficient if it is greater than or equal to the stoichiometric amount necessary to hydrolyze the protein, but water is mixed at a ratio of 10 to 50 parts by mass with respect to 1 part by mass of the protein. The temperature of the mixture at this stage is preferably 10 to 80 ° C. The mixture is sealed in a pressure vessel and heated so that the ultimate temperature of the mixture in the pressure vessel is 160 to 280 ° C, preferably 200 to 240 ° C. The heating time to reach the ultimate temperature is 10 to 90 minutes, preferably 20 to 60 minutes, and the rate of temperature increase at this time is preferably 3 to 20 ° C./minute. The atmospheric gas in the pressure vessel is replaced with N 2 gas in advance and pressurized.
第2工程は、第1工程終了後、耐圧容器内の温度を保持して加水分解を更に進める工程である。第2工程では、第1工程で到達した同温度を0〜20分間保持する。 The second step is a step of further proceeding the hydrolysis while maintaining the temperature in the pressure vessel after completion of the first step. In the second step, the same temperature reached in the first step is held for 0 to 20 minutes.
第3工程は、耐圧容器内の生成した加水分解物を冷却し、耐圧容器から取り出して液体部を分離し、分離した液体部を乾燥する工程である。 The third step is a step of cooling the hydrolyzate produced in the pressure vessel, taking it out of the pressure vessel, separating the liquid part, and drying the separated liquid part.
耐圧容器内には反応処理物に相当する加水分解物が生成し、この加水分解物は通常液体部と固体部とが混合した状態となっているので、デカンテーション、濾過、遠心分離等により液体部を分離し、分離した液体部をスプレードライ、ドラムドライ、フリーズドライ等の方法により乾燥して、蛋白質分解物を得ることができる。 A hydrolyzate corresponding to the reaction product is generated in the pressure vessel, and this hydrolyzate is usually in a state where the liquid part and the solid part are mixed. Therefore, the hydrolyzate is liquid by decantation, filtration, centrifugation, etc. The separated liquid part can be dried by a method such as spray drying, drum drying, freeze drying, etc. to obtain a protein degradation product.
亜臨界状態の水としては、上水、蒸留水、イオン交換水及び超純水等を用いることができる。また反応に用いる耐圧容器としては、使用温度と使用圧力に耐えられるものはいずれでも使用可能であるが、なかでもステンレス製の耐圧容器が好ましい。反応方式は連続式でもバッチ式でもいずれも可能である。 As the water in the subcritical state, clean water, distilled water, ion exchange water, ultrapure water, or the like can be used. As the pressure vessel used for the reaction, any one that can withstand the use temperature and the use pressure can be used, and among them, a pressure vessel made of stainless steel is preferable. The reaction system can be either continuous or batch.
本発明の製造方法によって得られる蛋白質分解物は、詳しくは後述するように、優れたACE阻害活性を示し、血圧降下剤として有用である。 As will be described in detail later, the protein degradation product obtained by the production method of the present invention exhibits excellent ACE inhibitory activity and is useful as a blood pressure lowering agent.
以上説明した本発明には、ゴマ種子由来の蛋白質からACE阻害活性を有する蛋白質分解物を安全に量産できるという効果がある。 The present invention described above has an effect that a protein degradation product having an ACE inhibitory activity can be safely mass-produced from a protein derived from sesame seeds.
以下、本発明の構成及び効果をより具体的にするため、実施例及び比較例を挙げるが、本発明がこれらの実施例に限定されるというものではない。尚、以下の実施例及び比較例において、部は質量部を、また%は質量%を意味する。 Hereinafter, in order to make the configuration and effects of the present invention more specific, examples and comparative examples will be described. However, the present invention is not limited to these examples. In the following Examples and Comparative Examples, “part” means “part by mass” and “%” means “% by mass”.
試験区分1(蛋白質分解物の製造−その1)
実施例1
生ゴマ種子をヘキサンで脱脂した後、0.05N水酸化ナトリウム水溶液中に浸漬し、加熱して、液温を55℃に保ちながら45分間撹拌し、蛋白質を抽出した。抽出物から遠心分離(8000×g、15分間)により残渣を除去し、残渣を除去した液体部を2N塩酸によりpHを4.5に調整し、等電点沈殿法により蛋白質を含む含水物を得た。
Test category 1 (Manufacture of protein degradation products-1)
Example 1
The raw sesame seeds were defatted with hexane, immersed in a 0.05N aqueous sodium hydroxide solution, heated, and stirred for 45 minutes while maintaining the liquid temperature at 55 ° C. to extract proteins. The residue is removed from the extract by centrifugation (8000 × g, 15 minutes), the pH of the liquid part from which the residue has been removed is adjusted to 4.5 with 2N hydrochloric acid, and the water-containing product containing protein is removed by isoelectric point precipitation. Obtained.
前記で得た蛋白質を含む含水物30gをステンレス製の耐熱容器に入れ、蒸留水200gを加えて混合物(蛋白質8.3g/水221.7g)とした。混合物の温度は25℃であった。蓋を閉じて耐圧容器内の気体をN2ガスで置換した後、排気バルブを閉じて耐圧容器内の圧力が3.0MPaになるまでN2ガスを圧入し、密封した。密封した耐圧容器内の混合物の温度が180℃に到達するまで7℃/分の昇温速度で加熱した。混合物の温度が180℃に到達したときの耐圧容器内の圧力は4.0MPaであった。混合物の温度が180℃に到達後、直ちに50℃まで冷却し、排気バルブを開いて復圧した後、蓋を開いて加水分解物を取り出した。取り出した加水分解物から遠心分離により水相を分離し、この水相を凍結乾燥して蛋白質分解物を得た。 30 g of the water-containing product containing the protein obtained above was put in a stainless heat-resistant container, and 200 g of distilled water was added to obtain a mixture (protein 8.3 g / water 221.7 g). The temperature of the mixture was 25 ° C. After the lid was closed and the gas in the pressure vessel was replaced with N 2 gas, the exhaust valve was closed and N 2 gas was injected and sealed until the pressure in the pressure vessel reached 3.0 MPa. The mixture was heated at a heating rate of 7 ° C./min until the temperature of the mixture in the sealed pressure vessel reached 180 ° C. The pressure in the pressure resistant container when the temperature of the mixture reached 180 ° C. was 4.0 MPa. When the temperature of the mixture reached 180 ° C., it was immediately cooled to 50 ° C., the exhaust valve was opened and the pressure was restored, and then the lid was opened and the hydrolyzate was taken out. The aqueous phase was separated from the extracted hydrolyzate by centrifugation, and this aqueous phase was freeze-dried to obtain a protein degradation product.
実施例2〜5及び比較例1〜2
実施例1と同様にして、但し表1に示した条件下で、実施例2〜5及び比較例1〜2の蛋白質分解物を得た。
Examples 2-5 and Comparative Examples 1-2
The protein degradation products of Examples 2 to 5 and Comparative Examples 1 to 2 were obtained in the same manner as in Example 1, but under the conditions shown in Table 1.
試験区分2(ACE阻害活性の測定−その1)
6.0mU(1Uは1分間に1μmolのヒプリル酸を生成する酵素力価)のウサギの肺アンジオテンシン変換酵素(シグマ社製)、5mmolのヒプリルーL―ヒスチジルーL−ロイシン(シグマ社製)、400mmolの塩化ナトリウム及び試験区分1で得た蛋白質分解物を濃度が1mg/mlとなるよう純水に溶解した水溶液100μgを、350μlのホウ酸緩衝液(pH8.3)中で撹拌して、液温を37℃に保ちながら30分間反応させた。1N塩酸を250μl添加して反応を停止させた後、1mlの酢酸エチルを加えて15秒間激しく撹拌した。遠心分離機(3000rpm×10分間)により、処理して内容物を分離し、酢酸エチル層を0.5ml採取した。採取したものを120℃の温度下で乾燥して溶媒を除去し、蒸留水1mlで再溶解して測定用試料とした。この測定用試料について、ヒプリル酸の吸収波長である波長228nmの吸光度(B)を測定した。蛋白質分解物を含有させずに同様に試験して吸光度(A)を測定し、以下の数1からACE阻害活性(%)を求めた。
Test Category 2 (Measurement of ACE inhibitory activity-1)
Rabbit lung angiotensin converting enzyme (manufactured by Sigma) of 6.0 mU (1 U is an enzyme titer that produces 1 μmol of hyprilic acid per minute), 5 mmol of hippuriu L-histidiru L-leucine (manufactured by Sigma), 400 mmol of 100 μg of an aqueous solution prepared by dissolving sodium chloride and the protein degradation product obtained in Test Category 1 in pure water so as to have a concentration of 1 mg / ml was stirred in 350 μl of borate buffer (pH 8.3), and the liquid temperature was adjusted. The reaction was allowed to proceed for 30 minutes while maintaining the temperature at 37 ° C. After stopping the reaction by adding 250 μl of 1N hydrochloric acid, 1 ml of ethyl acetate was added and vigorously stirred for 15 seconds. The contents were separated by processing with a centrifuge (3000 rpm × 10 minutes), and 0.5 ml of an ethyl acetate layer was collected. The collected sample was dried at a temperature of 120 ° C. to remove the solvent, and redissolved with 1 ml of distilled water to obtain a measurement sample. With respect to this measurement sample, the absorbance (B) at a wavelength of 228 nm, which is the absorption wavelength of hyperylic acid, was measured. The same test was carried out without containing a protein degradation product, the absorbance (A) was measured, and the ACE inhibitory activity (%) was determined from the following formula 1.
試験区分3(蛋白質分解物の製造−その2)
実施例6
試験区分1の実施例1と同様にして得た蛋白質30gをステンレス製の耐圧容器に入れ、蒸留水200mlを加えて混合物(蛋白質4.9g/水225.1g)とした。混合物の温度は25℃であった。蓋を閉じて耐圧容器内の気体をN2ガスで置換した後、排気バルブを閉じて耐圧容器内の圧力が3.0MPaになるまでN2ガスを圧入し、密封した。密封した耐圧容器内の混合物の温度が200℃に到達するまで7℃/分の昇温速度で加熱した。混合物の温度が200℃に到達したときの耐圧容器内の圧力は4.5MPaであった。混合物の温度が200℃に到達後、直ちに50℃まで冷却し、排気バルブを開いて復圧した後、蓋を開いて加水分解物を取り出した。取り出した加水分解物から遠心分離により水相を分離し、この水相を凍結乾燥して蛋白質分解物を得た。
Test Category 3 (Production of protein degradation product-2)
Example 6
30 g of the protein obtained in the same manner as in Example 1 of Test Category 1 was placed in a stainless steel pressure vessel, and 200 ml of distilled water was added to obtain a mixture (protein 4.9 g / water 225.1 g). The temperature of the mixture was 25 ° C. After the lid was closed and the gas in the pressure vessel was replaced with N 2 gas, the exhaust valve was closed and N 2 gas was injected and sealed until the pressure in the pressure vessel reached 3.0 MPa. The mixture was heated at a heating rate of 7 ° C./min until the temperature of the mixture in the sealed pressure vessel reached 200 ° C. The pressure in the pressure vessel when the temperature of the mixture reached 200 ° C. was 4.5 MPa. After the temperature of the mixture reached 200 ° C., it was immediately cooled to 50 ° C., the exhaust valve was opened and the pressure was restored, and then the lid was opened and the hydrolyzate was taken out. The aqueous phase was separated from the extracted hydrolyzate by centrifugation, and this aqueous phase was freeze-dried to obtain a protein degradation product.
実施例7
試験区分1の実施例1と同様にして得た蛋白質30gをステンレス製の耐圧容器に入れ、蒸留水200mlを加えて混合物(蛋白質4.9g/水225.1g)とした。混合物の温度は25℃であった。蓋を閉じて耐圧容器内の気体をN2ガスで置換した後、排気バルブを閉じて耐圧容器内の圧力が3.0MPaになるまでN2ガスを圧入し、密封した。密封した耐圧容器内の混合物の温度が200℃に到達するまで7℃/分の昇温速度で加熱した。混合物の温度が200℃に到達後、更に同温度を10分間保持した。保持中の耐圧容器内の圧力は4.5MPaであった。その後、直ちに50℃まで冷却し、排気バルブを開いて復圧した後、蓋を開いて加水分解物を取り出した。取り出した加水分解物から遠心分離により水相を分離し、この水相を凍結乾燥して蛋白質分解物を得た。
Example 7
30 g of the protein obtained in the same manner as in Example 1 of Test Category 1 was placed in a stainless steel pressure vessel, and 200 ml of distilled water was added to obtain a mixture (protein 4.9 g / water 225.1 g). The temperature of the mixture was 25 ° C. After the lid was closed and the gas in the pressure vessel was replaced with N 2 gas, the exhaust valve was closed and N 2 gas was injected and sealed until the pressure in the pressure vessel reached 3.0 MPa. The mixture was heated at a heating rate of 7 ° C./min until the temperature of the mixture in the sealed pressure vessel reached 200 ° C. After the temperature of the mixture reached 200 ° C., the same temperature was further maintained for 10 minutes. The pressure in the pressure vessel during the holding was 4.5 MPa. Thereafter, the mixture was immediately cooled to 50 ° C., the exhaust valve was opened and the pressure was restored, and then the lid was opened and the hydrolyzate was taken out. The aqueous phase was separated from the extracted hydrolyzate by centrifugation, and this aqueous phase was freeze-dried to obtain a protein degradation product.
実施例又は参考例8〜16
実施例6又は7と同様にして、但し表2に示した条件下で、実施例又は参考例8〜16の蛋白質分解物を得た。
Examples or Reference Examples 8 to 16
In the same manner as in Example 6 or 7, but under the conditions shown in Table 2, the protein degradation products of Examples or Reference Examples 8 to 16 were obtained.
試験区分4(ACE阻害活性の測定−その2)
試験区分2の測定と同様にして、但し蛋白質分解物の濃度を変えた数サンプルの水溶液を用意し、これらについてACE阻害活性(%)を求め、各ACE阻害活性を結ぶ線からACE阻害活性が50%のときの蛋白質分解物の濃度を算出し、阻害蛋白質分解物濃度(IC50)を求めた。結果を表2にまとめて示した。
Test category 4 (Measurement of ACE inhibitory activity-2)
Similar to the measurement in
試験区分5(血圧降下剤としての評価)
11週齢の高血圧自然発症ラット(日本チャールズリバー社)を温度22±3℃、湿度60±15%、換気回数12〜15回/時間及び照明12時間/日(7:00〜19:00)に設定した飼育室にて、水及び飼料(オリエンタル酵母社製)を自由摂取させて馴化飼育した。体重が270〜300g且つ収縮期血圧が160mmHg以上のラットを1群5匹にわけ、試験区分3の実施例8の蛋白質分解物を水に分散したものを体重1kg当たり1000mgの割合で経口投与した。投与後、非観血的血圧測定装置(BP−98A、ソフトロン社製)を用い、Tail−cuff法で、経時的に収縮期血圧、拡張期血圧、平均血圧、心拍数、体重を測定した。対照として、蛋白質分解物を投与しない群についても同様に測定した。測定値の平均値を図1〜4に示した。
Test category 5 (evaluation as antihypertensive agent)
Eleven weeks old spontaneously hypertensive rats (Nippon Charles River Co., Ltd.)
図1〜4からも明らかなように、本発明のACE阻害活性を有する蛋白質分解物は、経口投与後に血圧降下作用を示した。また経口投与後、心拍数の上昇や体重の増加等の傾向は見られなかった。 As is clear from FIGS. 1 to 4, the proteolysate having ACE inhibitory activity of the present invention exhibited a blood pressure lowering effect after oral administration. Moreover, after oral administration, there were no trends such as an increase in heart rate or an increase in body weight.
11〜14 本発明の蛋白質分解物による場合の折れ線
21〜24 対照の折れ線
11-14 Polygonal line when the protein degradation product of the present invention is used 21-24 Contrast line
Claims (4)
第1工程:ゴマ種子由来の蛋白質1質量部に対して水を10〜50質量部の割合で混合し、その混合物を耐圧容器内に密閉して、耐圧容器内の雰囲気ガスをN 2 ガスで置換し、与圧した後、耐圧容器内の混合物を10〜90分間で160〜280℃の到達温度となるよう且つ到達温度時の耐圧容器内の圧力が4.0〜8.0MPaとなるように加熱する工程。
第2工程:160〜280℃の同温度で0〜20分間保持する工程。
第3工程:耐圧容器内の生成した加水分解物を冷却し、耐圧容器から取り出して、液体部を分離し、分離した液体部を乾燥する工程。 A method for producing a protein degradation product, comprising a step including the following first step, second step and third step.
First step: 10 to 50 parts by mass of water is mixed with 1 part by mass of protein derived from sesame seeds, the mixture is sealed in a pressure vessel, and the atmosphere gas in the pressure vessel is N 2 gas. substituted, after pressurization, the pressure of the mixture 160 to 280 in the pressure vessel at by the Hare and reaching temperature becomes temperature reached ℃ in 10-90 minutes the pressure vessel becomes 4.0~8.0MPa heating to.
2nd process : The process hold | maintained for 0 to 20 minutes at the same temperature of 160-280 degreeC.
3rd process: The process which cools the produced | generated hydrolyzate in a pressure vessel, takes out from a pressure vessel, isolate | separates a liquid part, and dries the isolate | separated liquid part.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009240208A JP5561850B2 (en) | 2009-10-19 | 2009-10-19 | Method for producing protein degradation product |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009240208A JP5561850B2 (en) | 2009-10-19 | 2009-10-19 | Method for producing protein degradation product |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2011084533A JP2011084533A (en) | 2011-04-28 |
JP5561850B2 true JP5561850B2 (en) | 2014-07-30 |
Family
ID=44077764
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2009240208A Active JP5561850B2 (en) | 2009-10-19 | 2009-10-19 | Method for producing protein degradation product |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5561850B2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103005141A (en) * | 2012-12-17 | 2013-04-03 | 南昌大学 | Method for improving oxidation resistance and functional property of plant protein |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0817682B2 (en) * | 1986-07-25 | 1996-02-28 | 株式会社神戸製鋼所 | Method for producing low molecular weight protein |
JPH03123470A (en) * | 1989-10-05 | 1991-05-27 | Taiyo Fishery Co Ltd | Method for enhancing angiotensin conversion enzyme inhibiting activity in krill |
JP2820868B2 (en) * | 1993-08-27 | 1998-11-05 | 日清食品株式会社 | Angiotensin converting enzyme inhibitory protein degradation product |
JP2002247955A (en) * | 2001-02-23 | 2002-09-03 | Takashi Okazaki | Split product having high angiotensin converting enzyme- inhibiting action, method for producing the same and functional food |
JP2006246795A (en) * | 2005-03-10 | 2006-09-21 | Takai Seisakusho:Kk | Soybean processed product improved in functionality |
-
2009
- 2009-10-19 JP JP2009240208A patent/JP5561850B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2011084533A (en) | 2011-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2408601C2 (en) | Method of producing iron-containing succinylated casein | |
EP0014362A1 (en) | Method of debittering a protein hydrolysate and debittered hydrolysate obtained | |
JP2012244930A (en) | Method for producing collagen peptide from bonito bone as raw material | |
JP2018070632A (en) | Rice bran enzyme treatment composition | |
CN104447491B (en) | Hemifumarate and its intermediate and medical usage containing pyrrole ring proton pump inhibitor | |
JP5561850B2 (en) | Method for producing protein degradation product | |
JPS58170440A (en) | Beverage or food for health | |
WO2022168413A1 (en) | Method for producing deprestatin-containing composition | |
JP2737790B2 (en) | Food containing silk protein hydrolyzate and method for producing the same | |
KR20090129489A (en) | Composition for preventing or treating lung disease | |
JP5642346B2 (en) | Arteriosclerosis preventive agent, vascular intimal thickening inhibitor, and vascular endothelium contraction / dilation function improving agent | |
JP4862235B2 (en) | Blood sugar level rise inhibitor | |
JP2008247888A (en) | Hypotensive composition using koji | |
EP0487619B1 (en) | Von casein-beta ausgehendes verfahren zur herstellung von fraktionen, die mit biologisch aktiven peptiden angereichert sind sowie die so erhaltenen peptidfraktionen | |
CN1726221A (en) | Method for preparing hop bract polyphenols | |
JP2007297324A (en) | Peptide and method for producing the same, and angiotensin converting enzyme inhibitor | |
JP2820868B2 (en) | Angiotensin converting enzyme inhibitory protein degradation product | |
JP2009148248A (en) | Hypoallergenic agent | |
JP2007297325A (en) | Peptide and method for producing the same, and angiotensin converting enzyme inhibitor | |
JP5292633B2 (en) | Renal failure preventive agent | |
JP2009050212A (en) | Gradual acquisition method of rice ingredients | |
JP2007297327A (en) | Angiotensin converting enzyme inhibitor and method for producing the same | |
KR20120021590A (en) | A pharmaceutical composition for prevention or treatment of hypertension comprising enzymatic extracts from tilapia mossambica as an effective component | |
TWI414305B (en) | Agents for preventing renal failure | |
JP2002138100A (en) | Angiotensin converting enzyme inhibitor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20120801 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20140114 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140225 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20140609 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20140609 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5561850 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |